Skip to main content
. 2015 Feb 13;6(4):465–472. doi: 10.1111/jdi.12326

Table 1.

Clinical characteristics of patients

n 149
Age (years) 65.7 ± 9.3
Sex (male/female) 77/72
Body mass index (kg/m2) 24.0 ± 4.2
Systolic blood pressure (mmHg) 129.6 ± 14.6
Diastolic blood pressure (mmHg) 72.4 ± 10.4
HbA1c (%) 6.9 ± 0.9
Total cholesterol (mmol/L) 4.8 ± 0.8
High-density lipoprotein cholesterol (mmol/L) 1.6 ± 0.4
Low-density lipoprotein cholesterol (mmol/L) 2.6 ± 0.8
Triglycerides (mmol/L) 1.5 ± 1.0
Uric acid (μmol/L) 298.4 ± 78.9
Estimated glomerular filtration rate (mL/min/1.73 m2) 77.9 ± 21.7
Urinary albumin excretion (mg/g creatinine) 46.9 ± 94.1
No. metabolic risk factors 2.5 ± 2.0
Metabolic syndrome (–/+) 82/67
Insulin treatment (–/+) 116/33
Antihypertensive drugs (–/+) 79/70
Statins (–/+) 91/58
Total energy intake (kcal) 1821.5 ± 400.1
Carbohydrate intake (g) 248.8 ± 60.9
Protein intake (g) 67.2 ± 18.5
Animal protein intake (g) 36.1 ± 14.4
Vegetable protein intake (g) 31.1 ± 8.4
Fat intake (g) 53.3 ± 20.2
Animal fat intake (g) 23.3 ± 10.5
Vegetable fat intake (g) 29.9 ± 12.9
Sodium intake (g) 10.5 ± 3.5
Carbohydrate energy/total energy (%) 56.9 ± 7.7
Protein energy/total energy (%) 15.3 ± 2.4
Fat energy/total energy (%) 26.9 ± 6.4
Potential renal acid load score (mEq/day) 5.7 ± 11.8
Net endogenous acid production score (mEq/day) −8.7 ± 0.3

Data are number of patients or mean ± standard deviation.

HbA1c, hemoglobin A1c.